Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantNOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, SOLUTION
SUBCUTANEOUS
Medical Information
H01AC07
Manufacturer Information
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Novo Nordisk A/S (Formulation, Filling and Primary packager)
Active Ingredients
Documents
Package Inserts
Sogroya Solution for Injection in PFP 10mg per 1.5ml PI and IFU.pdf
Approved: April 14, 2025